Indirect comparisons: the mesh and mess of clinical trials

scientific article published in October 2006

Indirect comparisons: the mesh and mess of clinical trials is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1016/S0140-6736(06)69615-3
P698PubMed publication ID17071265

P50authorJohn IoannidisQ6251482
P2860cites workAntibiotics for acute pyelonephritis in childrenQ24244919
Indirect comparisons of competing interventionsQ28183606
The results of direct and indirect treatment comparisons in meta-analysis of randomized controlled trialsQ29619501
Better reporting of harms in randomized trials: an extension of the CONSORT statementQ33983100
Reporting of noninferiority and equivalence randomized trials: an extension of the CONSORT statementQ33993977
Simultaneous comparison of multiple treatments: combining direct and indirect evidence.Q34081552
Randomised trials comparing chemotherapy regimens for advanced non-small cell lung cancer: biases and evolution over timeQ35558566
Clinical efficacy of antiretroviral combination therapy based on protease inhibitors or non-nucleoside analogue reverse transcriptase inhibitors: indirect comparison of controlled trialsQ35629103
Initial highly-active antiretroviral therapy with a protease inhibitor versus a non-nucleoside reverse transcriptase inhibitor: discrepancies between direct and indirect meta-analysesQ36637482
Validity of indirect comparison for estimating efficacy of competing interventions: empirical evidence from published meta-analysesQ39735046
Treatment for adult HIV infection: 2004 recommendations of the International AIDS Society-USA Panel.Q50145200
Limited benefit of antiretroviral resistance testing in treatment-experienced patients: a meta-analysisQ53877989
Network meta-analysis for indirect treatment comparisonsQ74720205
P433issue9546
P407language of work or nameEnglishQ1860
P304page(s)1470-1472
P577publication date2006-10-01
P1433published inThe LancetQ939416
P1476titleIndirect comparisons: the mesh and mess of clinical trials
P478volume368

Reverse relations

cites work (P2860)
Q94445656A Bayesian approach to discrete multiple outcome network meta-analysis
Q35237327A pragmatic view on pragmatic trials
Q40956038An alternative parameterization of Bayesian logistic hierarchical models for mixed treatment comparisons
Q35553233An assessment of the methodological quality of published network meta-analyses: a systematic review
Q38520487Assessing key assumptions of network meta-analysis: a review of methods
Q43058828Bias in identification of the best treatment in a Bayesian network meta-analysis for binary outcome: a simulation study
Q84975716Calculating additive treatment effects from multiple randomized trials provides useful estimates of combination therapies
Q37897625Clinical comparability of the new antiepileptic drugs in refractory partial epilepsy: a systematic review and meta-analysis.
Q37133396Direct versus indirect comparisons: a summary of the evidence
Q46609331Economic evaluation of Sinfrontal in the treatment of acute maxillary sinusitis in adults
Q21093304Effectiveness of smoking cessation therapies: a systematic review and meta-analysis
Q36966424Evaluation of networks of randomized trials
Q38005597Evidence-based surgery: barriers, solutions, and the role of evidence synthesis
Q37832531Factors determining response to antiepileptic drugs in randomized controlled trials. A systematic review and meta-analysis
Q24236814Fluvoxamine versus other anti-depressive agents for depression
Q37764847Frequency of treatment-effect modification affecting indirect comparisons: a systematic review
Q30251972GetReal in network meta-analysis: a review of the methodology
Q57542870Indirect and mixed-treatment comparison, network, or multiple-treatments meta-analysis: many names, many benefits, many concerns for the next generation evidence synthesis tool
Q37572176Integration of evidence from multiple meta-analyses: a primer on umbrella reviews, treatment networks and multiple treatments meta-analyses
Q46894544Interpreting Indirect Treatment Comparisons and Network Meta-Analysis for Health-Care Decision Making: Report of the ISPOR Task Force on Indirect Treatment Comparisons Good Research Practices: Part 1
Q30578166Meta-analysis of clinical trial safety data in a drug development program: Answers to frequently asked questions
Q33403399Metastatic renal cell cancer treatments: an indirect comparison meta-analysis
Q37433313Methodological problems in the use of indirect comparisons for evaluating healthcare interventions: survey of published systematic reviews
Q24240125Milnacipran versus other antidepressive agents for depression
Q24234046Mirtazapine versus other antidepressive agents for depression
Q35089776Multiple treatment comparison meta-analyses: a step forward into complexity.
Q37344525Multiple-treatments meta-analysis of chemotherapy and targeted therapies in advanced breast cancer
Q47131728Network meta-analysis: application and practice using Stata
Q35014739Nevirapine-based regimens in HIV-infected antiretroviral-naive patients: systematic review and meta-analysis of randomized controlled trials
Q38069844Preservation Solutions for Liver Transplantation in Adults: Celsior versus Custodiol: A Systematic Review and Meta-analysis With an Indirect Comparison of Randomized Trials
Q37129735Progress update: Pharmacological treatment of Alzheimer's disease.
Q42748619Quantifying nonsteroidal anti-inflammatory drug (NSAID) risk: can combining the evidence with the use of a network meta-analysis provide a solution?
Q37195565Reasons or excuses for avoiding meta-analysis in forest plots
Q28291828Secondary prophylaxis of variceal bleeding for cirrhotic patients: a multiple-treatments meta-analysis
Q46987043Survival and disease-progression benefits with treatment regimens for advanced colorectal cancer: a meta-analysis
Q37641067The use of older studies in meta-analyses of medical interventions: a survey.
Q64247210Tramadol/dexketoprofen (TRAM/DKP) compared with tramadol/paracetamol in moderate to severe acute pain: results of a randomised, double-blind, placebo and active-controlled, parallel group trial in the impacted third molar extraction pain model (DAVID
Q39022643Treatment decisions in multiple sclerosis - insights from real-world observational studies.
Q38524041Use of indirect comparison methods in systematic reviews: a survey of Cochrane review authors.
Q51924377Validity of indirect comparisons in meta-analysis.
Q54635351["Be careful with indirect comparisons: the case of the new oral anticoagulants"].
Q82862517[Closing evidence gaps]

Search more.